Italia markets open in 3 hours 59 minutes

Globus Medical, Inc. (GMED)

NYSE - NYSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
50,43+0,64 (+1,29%)
Alla chiusura: 04:00PM EDT
51,90 +1,47 (+2,91%)
Dopo ore: 05:22PM EDT

Globus Medical, Inc.

2560 General Armistead Avenue
Audubon, PA 19403
United States
610 930 1800
https://www.globusmedical.com

Settore/iHealthcare
SettoreMedical Devices
Impiegati a tempo pieno5.000

Figure dirigenziali chiave

NomeTitoloRetribuzioneEsercitateAnno di nascita
Mr. David C. PaulCo-Founder & Executive Chairman1,21MN/D1967
Mr. Daniel T. ScavillaPresident, CEO & Director1,37MN/D1965
Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Governance aziendale

L'ISS Governance QualityScore di Globus Medical, Inc. al 29 aprile 2024 è 10. I criteri di valutazione fondamentali sono revisione: 8; Consiglio di Amministrazione: 10; diritti degli azionisti: 10; retribuzione: 6.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.